Mitochondrial p53 prompts Bak and causes disruption of a Bak-Mcl1 advanced.

 

• The tumour suppressor exercise of the p53 protein has been defined by its means to induce apoptosis in response to quite a lot of mobile stresses.

 

 

• Thus, understanding the mechanism by which p53 features within the execution of cell demise pathways is of appreciable significance in most cancers biology.

 

 

• Latest research have indicated that p53 has a direct signalling position at mitochondria within the induction of apoptosis, though the mechanisms concerned usually are not utterly understood.

DNA Polymerase for PAGE Enzyme

 

• Right here we present that, after cell stress, p53 interacts with the pro-apoptotic mitochondrial membrane protein Bak. Interplay of p53 with Bak causes oligomerization of Bak and launch of cytochrome c from mitochondria.

 

Guanine Nucleotide Exchange Factor For Rab-3A (RAB3IL1) Antibody

 

• Notably, we present that formation of the p53-Bak advanced coincides with lack of an interplay between Bak and the anti-apoptotic Bcl2-family member Mcl1. These outcomes are in step with a mannequin through which p53 and Mcl1 have opposing results on mitochondrial apoptosis by interacting with, and modulating the exercise of, the demise effector Bak.

 

VHL Antibody
AF6292	Affbiotech	200ul	EUR 420

VHL antibody
70R-34605	Fitzgerald	100 ug	EUR 392.4
Description: Purified Rabbit polyclonal VHL antibody

VHL Antibody
32075-100ul	SAB	100ul	EUR 302.4

VHL Antibody
ABD6104	Lifescience Market	100 ug	EUR 525.6

VHL Antibody
ABF6292	Lifescience Market	100 ug	EUR 525.6

VHL Antibody
1-CSB-PA991849	Cusabio	EUR 380.40 EUR 292.80	100ul 50ul
Description: A polyclonal antibody against VHL. Recognizes VHL from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:10000, IHC:1:50-1:200

VHL Antibody
DF6104	Affbiotech	200ul	EUR 420

VHL Antibody
1-CSB-PA060067	Cusabio	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against VHL. Recognizes VHL from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/40000

VHL Antibody
1-CSB-PA071125	Cusabio	EUR 380.40 EUR 292.80	100ul 50ul
Description: A polyclonal antibody against VHL. Recognizes VHL from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100

VHL Antibody
1-CSB-PA876839	Cusabio	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against VHL. Recognizes VHL from Human. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC-p:1:50-300, ELISA:1:10000-20000

VHL Antibody
CSB-PA025852KA01HU-	Cusabio	each	EUR 402
Description: A polyclonal antibody against VHL. Recognizes VHL from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

VHL Antibody
CSB-PA025852KA01HU-100ul	Cusabio	100ul	EUR 466.8
Description: A polyclonal antibody against VHL. Recognizes VHL from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

VHL Antibody
F49681-0.05ML	NSJ Bioreagents	0.05 ml	EUR 140.25
Description: Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of VHL gene is the basis of familial inheritance of VHL syndrome. The protein is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein.

VHL Antibody
F49681-0.2ML	NSJ Bioreagents	0.2 ml	EUR 322.15
Description: Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of VHL gene is the basis of familial inheritance of VHL syndrome. The protein is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein.

VHL Antibody
F49682-0.08ML	NSJ Bioreagents	0.08 ml	EUR 140.25
Description: Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of VHL gene is the basis of familial inheritance of VHL syndrome. The protein is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein.

VHL Antibody
F49682-0.4ML	NSJ Bioreagents	0.4 ml	EUR 330.65
Description: Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of VHL gene is the basis of familial inheritance of VHL syndrome. The protein is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein.

VHL Antibody
R35773-100UG	NSJ Bioreagents	100 ug	EUR 339.15
Description: Additional name(s) for this target protein: Von Hippel-Lindau tumor suppressor, VHL1

anti- VHL antibody
FNab09402	FN Test	100µg	EUR 658.5
Description: Antibody raised against VHL

anti- VHL antibody
FNab10175	FN Test	100µg	EUR 606.3
Description: Antibody raised against VHL

Human VHL Antibody
32825-05111	AssayPro	150 ug	EUR 313.2

VHL (pS68) Antibody
abx219320-100ug	Abbexa	100 ug	EUR 526.8

VHL Conjugated Antibody
C32075	SAB	100ul	EUR 476.4

VHL Polyclonal Antibody
46866-100ul	SAB	100ul	EUR 302.4

VHL Polyclonal Antibody
46866-50ul	SAB	50ul	EUR 224.4

VHL Polyclonal Antibody
ABP56500-003ml	Abbkine	0.03ml	EUR 189.6
Description: A polyclonal antibody for detection of VHL from Human, Mouse, Rat. This VHL antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human VHL around the non-phosphorylation site of S68

VHL Polyclonal Antibody
ABP56500-01ml	Abbkine	0.1ml	EUR 346.8
Description: A polyclonal antibody for detection of VHL from Human, Mouse, Rat. This VHL antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human VHL around the non-phosphorylation site of S68

VHL Polyclonal Antibody
ABP56500-02ml	Abbkine	0.2ml	EUR 496.8
Description: A polyclonal antibody for detection of VHL from Human, Mouse, Rat. This VHL antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human VHL around the non-phosphorylation site of S68

VHL Polyclonal Antibody
ABP60891-003ml	Abbkine	0.03ml	EUR 189.6
Description: A polyclonal antibody for detection of VHL from Human. This VHL antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human VHL protein at amino acid sequence of 1-50

VHL Polyclonal Antibody
ABP60891-01ml	Abbkine	0.1ml	EUR 346.8
Description: A polyclonal antibody for detection of VHL from Human. This VHL antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human VHL protein at amino acid sequence of 1-50

VHL Polyclonal Antibody
ABP60891-02ml	Abbkine	0.2ml	EUR 496.8
Description: A polyclonal antibody for detection of VHL from Human. This VHL antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human VHL protein at amino acid sequence of 1-50

VHL Polyclonal Antibody
ES7499-100ul	ELK Biotech	100ul	EUR 334.8
Description: A Rabbit Polyclonal antibody against VHL from Human/Mouse/Rat. This antibody is tested and validated for IHC, WB, ELISA

VHL Polyclonal Antibody
ES7499-50ul	ELK Biotech	50ul	EUR 248.4
Description: A Rabbit Polyclonal antibody against VHL from Human/Mouse/Rat. This antibody is tested and validated for IHC, WB, ELISA

VHL Polyclonal Antibody
ES8746-100ul	ELK Biotech	100ul	EUR 334.8
Description: A Rabbit Polyclonal antibody against VHL from Human. This antibody is tested and validated for IHC, WB, ELISA

VHL Polyclonal Antibody
ES8746-50ul	ELK Biotech	50ul	EUR 248.4
Description: A Rabbit Polyclonal antibody against VHL from Human. This antibody is tested and validated for IHC, WB, ELISA

Polyclonal VHL Antibody (C-term)
APR10723G	Leading Biology	0.1ml	EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human VHL (C-term). This antibody is tested and proven to work in the following applications:

Human VHL Antibody (Biotin Conjugate)
32825-05121	AssayPro	150 ug	EUR 442.8

VHL (Phospho- Ser68) Antibody
ABF8334	Lifescience Market	100 ug	EUR 525.6

VHL (Phospho-Ser68) Antibody
12654-100ul	SAB	100ul	EUR 302.4

VHL (Phospho-Ser68) Antibody
12654-50ul	SAB	50ul	EUR 224.4

VHL (phospho Ser68) Polyclonal Antibody
ABP56499-003ml	Abbkine	0.03ml	EUR 189.6
Description: A polyclonal antibody for detection of VHL phospho Ser68) from Human, Mouse, Rat. This VHL phospho Ser68) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human VHL around the phosphorylation site of S68

VHL (phospho Ser68) Polyclonal Antibody
ABP56499-01ml	Abbkine	0.1ml	EUR 346.8
Description: A polyclonal antibody for detection of VHL phospho Ser68) from Human, Mouse, Rat. This VHL phospho Ser68) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human VHL around the phosphorylation site of S68

VHL (phospho Ser68) Polyclonal Antibody
ABP56499-02ml	Abbkine	0.2ml	EUR 496.8
Description: A polyclonal antibody for detection of VHL phospho Ser68) from Human, Mouse, Rat. This VHL phospho Ser68) antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human VHL around the phosphorylation site of S68

VHL (phospho Ser68) Polyclonal Antibody
ES7498-100ul	ELK Biotech	100ul	EUR 334.8
Description: A Rabbit Polyclonal antibody against VHL (phospho Ser68) from Human/Mouse/Rat. This antibody is tested and validated for IHC, WB, ELISA

VHL (phospho Ser68) Polyclonal Antibody
ES7498-50ul	ELK Biotech	50ul	EUR 248.4
Description: A Rabbit Polyclonal antibody against VHL (phospho Ser68) from Human/Mouse/Rat. This antibody is tested and validated for IHC, WB, ELISA

Von Hippel Lindau Tumor Suppressor (VHL) Antibody
20-abx210322	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Von Hippel Lindau Tumor Suppressor (vHL) Antibody
20-abx175113	Abbexa	EUR 1095.60 EUR 560.40	1 mg 200 ug

Von Hippel Lindau Tumor Suppressor (VHL) Antibody
20-abx211119	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Von Hippel Lindau Tumor Suppressor (VHL) Antibody
20-abx326550	Abbexa	EUR 376.80 EUR 292.80	100 ug 50 ug

Von Hippel Lindau Tumor Suppressor (vHL) Antibody
20-abx131162	Abbexa	EUR 543.60 EUR 159.60 EUR 1562.40 EUR 744.00 EUR 410.40	100 ug 10 ug 1 mg 200 ug 50 ug

Von Hippel Lindau Tumor Suppressor (VHL) Antibody
20-abx323201	Abbexa	EUR 376.80 EUR 292.80	100 ug 50 ug

Monoclonal VHL Antibody (monoclonal) (M01), Clone: 1G12
APR10724G	Leading Biology	0.1mg	EUR 580.8
Description: A Monoclonal antibody against Human VHL (monoclonal) (M01). The antibodies are raised in mouse and are from clone 1G12. This antibody is applicable in WB and IF, E

Human VHL AssayLite Antibody (RPE Conjugate)
32825-05151	AssayPro	150 ug	EUR 513.6

Human VHL AssayLite Antibody (APC Conjugate)
32825-05161	AssayPro	150 ug	EUR 513.6

Human VHL AssayLite Antibody (FITC Conjugate)
32825-05141	AssayPro	150 ug	EUR 513.6

Human VHL AssayLite Antibody (PerCP Conjugate)
32825-05171	AssayPro	150 ug	EUR 565.2

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
20-abx137392	Abbexa	EUR 844.80 EUR 393.60 EUR 276.00	100 ug 20 ug 5 ug

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx239402-100ug	Abbexa	100 ug	EUR 610.8

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx219331-100ug	Abbexa	100 ug	EUR 526.8

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx117007-100ug	Abbexa	100 ug	EUR 560.4

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx032864-400ul	Abbexa	400 ul	EUR 627.6

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx032864-80l	Abbexa	80 µl	EUR 343.2

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx032865-400ul	Abbexa	400 ul	EUR 627.6

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx032865-80l	Abbexa	80 µl	EUR 343.2

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
20-abx126781	Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx125410-50ul	Abbexa	50 ul	EUR 427.2

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx431703-200ul	Abbexa	200 ul	EUR 460.8

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
20-abx000699	Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody
abx012353-100ug	Abbexa	100 ug	EUR 526.8

VHL (Phospho-Ser68) Polyclonal Conjugated Antibody
C12654	SAB	100ul	EUR 476.4

VHL/ Rat VHL ELISA Kit
ELA-E1894r	Lifescience Market	96 Tests	EUR 1063.2

Vhl/ Rat Vhl ELISA Kit
ELI-06080r	Lifescience Market	96 Tests	EUR 1063.2

Von Hippel-Lindau Disease Tumor Suppressor (VHL) Antibody (Biotin)
abx431704-200ul	Abbexa	200 ul	EUR 460.8

Anti-VHL antibody
PAab09402	Lifescience Market	100 ug	EUR 463.2

Anti-VHL Antibody
STJ502735	St John's Laboratory	100 µg	EUR 571.2

Anti-VHL antibody
STJ70964	St John's Laboratory	100 µg	EUR 430.8

Anti-VHL antibody
STJ113440	St John's Laboratory	50 µl	EUR 332.4
Description: Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial inheritance of VHL syndrome. The protein encoded by this gene is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein. Alternatively spliced transcript variants encoding distinct isoforms have been observed.

Anti-VHL antibody
STJ113742	St John's Laboratory	100 µl	EUR 332.4
Description: Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial inheritance of VHL syndrome. The protein encoded by this gene is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein. Alternatively spliced transcript variants encoding distinct isoforms have been observed.

Anti-VHL antibody
STJ26089	St John's Laboratory	100 µl	EUR 332.4
Description: Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial inheritance of VHL syndrome. The protein encoded by this gene is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein. Alternatively spliced transcript variants encoding distinct isoforms have been observed.

Anti-VHL antibody
STJ118733	St John's Laboratory	100 µl	EUR 332.4

Anti-VHL antibody
STJ96241	St John's Laboratory	200 µl	EUR 236.4
Description: Rabbit polyclonal to VHL.

 

 

SirT3 suppresses hypoxia inducible issue 1α and tumor development by inhibiting mitochondrial ROS manufacturing.

 

 

• The position of oncoproteins and tumor suppressor proteins in selling the malignant transformation of mammalian cells by affecting properties reminiscent of proliferative signalling, cell cycle regulation and altered adhesion is effectively established.

 

Taq DNA Polymerase (Recombinant)

 

• Chemical compounds, viruses and radiation are additionally typically accepted as brokers that generally induce mutations within the genes encoding these most cancers-causing proteins, thereby giving rise to most cancers. Nevertheless, more moderen proof signifies the significance of two advertditional key components imposed on proliferating cells which can be concerned in transformation to malignancy and these are hypoxia and/or aggravating circumstances of nutrient deprivation (e.g. lack of glucose).

 

 

 

 

• These two further triggers can provoke and promote the method of malignant transformation when a low share of cells overcome and escape mobile senescence. It’s turning into obvious that hypoxia causes the progressive elevation in mitochondrial ROS production (continual ROS) which over time results in stabilization of cells through elevated HIF-2alpha expression, enabling cells to outlive with sustained ranges of elevated ROS.

 

 

Recombination Signal Binding Protein For Immunoglobulin Kappa J Region (RBPJ) Antibody

 

• In cells below hypoxia and/or low glucose, DNA mismatch restore processes are repressed by HIF-2alpha and so they frequently accumulate mitochondrial ROS-induced oxidative DNA injury and rising numbers of mutations driving the malignant transformation course of.

 

 

 

• Latest proof additionally signifies that the ensuing mutated most cancers-causing proteins suggestions to amplify the method by immediately affecting mitochondrial operate in combinatorial ways in which intersect to play a serious position in selling a vicious spiral of malignant cell transformation.

 

 

 

• Consequently, many malignant course ofes contain intervals of elevated mitochondrial ROS manufacturing when a number of cells survive the extra frequent technique of oxidative injury induced cell senescence and demise. The few cells escaping elimination emerge with oncogenic mutations and survive to change into immortalized tumors.

 

 

 

• This evaluation focuses on evidence highlighting the position of mitochondria as drivers of elevated ROS manufacturing throughout malignant transformation and therefore, their potential as targets for most cancers remedy. The evaluation is organized into 5 fundamental sections regarding totally different features of “mitochondrial malignancy”.

 

 

 

• The primary considerations the features of mitochondrial ROS and its significance as a pacesetter for cell development versus senescence and demise. The second considers the obtainable proof that mobile stress within the type of hypoxic and/or hypoglycaemic conditions signify two of the main triggering occasions for most cancers and the way oncoproteins reinforce this course of by altering gene expression to deliver a couple of frequent set of modifications in mitochondrial operate and exercise in most cancers cells.

 

 

 

• The third part presents proof that oncoproteins and tumor suppressor proteins bodily localize to the mitochondria in most cancers cells the place they immediately regulate malignant mitochondrial packages, together with apoptosis.

 

 

 

 

• The fourth part covers frequent mutational modifications within the mitochondrial genome as they relate to malignancy and the connection to the opposite three areas. The final part considerations the relevance of those findings, their significance and significance for novel focused approaches to anti–most cancers remedy and selective triggering in most cancers cells of the mitochondrial apoptotic pathway.

 

ProtoGlow ECL 200ml Kit
NAT1010	National Diagnostics	EACH	EUR 354

ProtoGlow ECL 500ml Kit
NAT1012	National Diagnostics	EACH	EUR 627.6

100G Acrylamide
NAT1014	National Diagnostics	100G	EUR 120

500G Acrylamide
NAT1016	National Diagnostics	500G	EUR 261.6

1KG Acrylamide
NAT1018	National Diagnostics	1KG	EUR 412.8

25G AquaPor LE
NAT1020	National Diagnostics	25G	EUR 132

100G AquaPor LE GTAC
NAT1022	National Diagnostics	100G	EUR 250.8

500G AquaPor LE GTAC
NAT1024	National Diagnostics	500G	EUR 878.4

25G AquaPor ES
NAT1026	National Diagnostics	25G	EUR 152.4

100G AquaPor ES
NAT1028	National Diagnostics	100G	EUR 350.4

25G AquaPor LM
NAT1030	National Diagnostics	25G	EUR 288

100G AquaPor LM
NAT1032	National Diagnostics	100G	EUR 860.4

25G AquaPor HR
NAT1034	National Diagnostics	25G	EUR 236.4

100G AquaPor HR
NAT1036	National Diagnostics	100G	EUR 592.8

25G AquaPor 3:1
NAT1038	National Diagnostics	25G	EUR 250.8

100G AquaPor 3:1
NAT1040	National Diagnostics	100G	EUR 570

25G Bis (Methylene Bis-Acrylamide)
NAT1042	National Diagnostics	25G	EUR 100.8

25G DATD Ultrapure
NAT1044	National Diagnostics	25G	EUR 168

250G Glycine
NAT1046	National Diagnostics	250G	EUR 94.8

1KG Glycine Ultrapure
NAT1048	National Diagnostics	1KG	EUR 128.4

250G Tris
NAT1050	National Diagnostics	250G	EUR 102

1KG Tris Ultrapure
NAT1052	National Diagnostics	1KG	EUR 177.6

100G Tricine
NAT1054	National Diagnostics	100G	EUR 120

100G Ion Exchange Resin (mixed bed)
NAT1056	National Diagnostics	100G	EUR 96

25G Riboflavin
NAT1058	National Diagnostics	25G	EUR 96

25ML TEMED
NAT1060	National Diagnostics	25ML	EUR 99.6

25G Ammonium Persulfate
NAT1062	National Diagnostics	25G	EUR 96

100G Ammonium Persulfate
NAT1064	National Diagnostics	100G	EUR 118.8

1G Dithiothreitol (DTT)
NAT1066	National Diagnostics	1G	EUR 103.2

5G Dithiothreitol (DTT)
NAT1068	National Diagnostics	5G	EUR 183.6

50ML 2-Mercaptoethanol
NAT1070	National Diagnostics	50ML	EUR 112.8

100G SDS Ultrapure
NAT1072	National Diagnostics	100G	EUR 111.6

1KG SDS Ultrapure
NAT1074	National Diagnostics	1KG	EUR 457.2

250G Urea
NAT1076	National Diagnostics	250G	EUR 98.4

1KG Urea
NAT1078	National Diagnostics	1KG	EUR 138

450ML Glycerol Ultrapure
NAT1080	National Diagnostics	450ML	EUR 132

200ML Tween 20 Ultrapure
NAT1082	National Diagnostics	200ML	EUR 132

1L Tween 20
NAT1084	National Diagnostics	1L	EUR 169.2

200ML Formamide
NAT1086	National Diagnostics	200ML	EUR 111.6

500ML Boric Acid
NAT1088	National Diagnostics	500ML	EUR 103.2

100G EDTA
NAT1090	National Diagnostics	100G	EUR 94.8

500G EDTA
NAT1092	National Diagnostics	500G	EUR 177.6

GelDry Film 11 X 12 cm
NAT1094	National Diagnostics	PK50	EUR 100.8

25ML Formamide CE
NAT1096	National Diagnostics	25ML	Ask for price

25ML Glass Bond
NAT1098	National Diagnostics	25ML	EUR 158.4

450ML Glass Free
NAT1100	National Diagnostics	450ML	EUR 196.8

GelDry Film 22.5 X 22.5 cm
NAT1102	National Diagnostics	PK50	EUR 130.8

1L DEPC Treated Water
NAT1104	National Diagnostics	1L	EUR 120

Sterling Rapid Silver Stain Kit
NAT1106	National Diagnostics	1KIT	EUR 265.2

1L ProtoBlue Safe
NAT1108	National Diagnostics	1L	EUR 159.6

4L ProtoBlue Safe
NAT1110	National Diagnostics	4L	EUR 282

1L ProtoStain Blue
NAT1112	National Diagnostics	1L	EUR 164.4

25ML Nuclistain
NAT1114	National Diagnostics	25ML	EUR 128.4

450ML AcrylaGel 30%
NAT1116	National Diagnostics	450ML	EUR 128.4

1L AcrylaGel 30%
NAT1118	National Diagnostics	1L	EUR 177.6

450ML Bis-AcrylaGel 2%
NAT1120	National Diagnostics	450ML	EUR 98.4

1L Bis-AcrylaGel 2%
NAT1122	National Diagnostics	1L	EUR 111.6

450ML UreaGel 29:1 Concentrate
NAT1124	National Diagnostics	450ML	EUR 133.2

1L UreaGel 29:1 Concentrate
NAT1126	National Diagnostics	1L	EUR 183.6

UreaGel 29:1 System 1L Kit
NAT1128	National Diagnostics	EACH	EUR 171.6

UreaGel 29:1 System 2.2L Kit
NAT1130	National Diagnostics	EACH	EUR 253.2

450ML SequaGel UreaGel Concentrate
NAT1132	National Diagnostics	450ML	EUR 126

1L SequaGel UreaGel Concentrate
NAT1134	National Diagnostics	1L	EUR 160.8

SequaGel Sequencing System 1L Kit
NAT1136	National Diagnostics	1KIT	EUR 171.6

SequaGel Sequencing System 2.2L Kit
NAT1138	National Diagnostics	EACH	EUR 253.2

100ML SequaGel Buffer
NAT1140	National Diagnostics	100ML	EUR 80.4

200ML SequaGel UreaGel Buffer
NAT1142	National Diagnostics	200ML	EUR 84

450ML SequaGel UreaGel-6
NAT1144	National Diagnostics	450ML	EUR 115.2

1L SequaGel UreaGel-6
NAT1146	National Diagnostics	1L	EUR 151.2

450ML SequaGel UreaGel-8
NAT1148	National Diagnostics	450ML	EUR 115.2

1L SequaGel UreaGel-8
NAT1150	National Diagnostics	1L	EUR 151.2

450ML SequaGel UreaGel Diluent
NAT1152	National Diagnostics	450ML	EUR 90

1L SequaGel UreaGel Diluent
NAT1154	National Diagnostics	1L	EUR 103.2

90ML SequaGel Complete Buffer
NAT1156	National Diagnostics	90ML	EUR 79.2

200ML SequaGel UreaGel Complete Buffer
NAT1158	National Diagnostics	200ML	EUR 85.2

450ML SequaGel XR
NAT1160	National Diagnostics	450ML	EUR 126

1L SequaGel XR
NAT1162	National Diagnostics	1L	EUR 165.6

100ML SequaGel XR Concentrate
NAT1164	National Diagnostics	100ML	EUR 128.4

450ML SequaGel XR Concentrate
NAT1166	National Diagnostics	450ML	EUR 361.2

200ML SequaGel MD Monomer Solution
NAT1168	National Diagnostics	200ML	EUR 220.8

SequaGel MD SSCP Kit
NAT1170	National Diagnostics	1KIT	EUR 253.2

SequaGel MD Heteroduplex Kit
NAT1172	National Diagnostics	EACH	EUR 265.2

1.2ML SequaGel MD SSCP Stop Solution
NAT1174	National Diagnostics	1.2ML	EUR 85.2

450ML AccuGel 19:1 (30%)
NAT1176	National Diagnostics	450ML	EUR 126

1L AccuGel 19:1 (30%)
NAT1178	National Diagnostics	1L	EUR 165.6

450ML AccuGel 19:1 (40%)
NAT1180	National Diagnostics	450ML	EUR 130.8

1L AccuGel 19:1 (40%)
NAT1182	National Diagnostics	1L	EUR 168

450ML AccuGel 29:1 (30%)
NAT1184	National Diagnostics	450ML	EUR 126

quotation: istanbul escort